↓ Skip to main content

Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis

Overview of attention for article published in PLOS ONE, May 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs
2 blogs

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
49 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis
Published in
PLOS ONE, May 2008
DOI 10.1371/journal.pone.0002291
Pubmed ID
Authors

Andre C. Kalil, Junfeng Sun

Abstract

Five pivotal clinical trials (Intensive Insulin Therapy; Recombinant Human Activated Protein C [rhAPC]; Low-Tidal Volume; Low-Dose Steroid; Early Goal-Directed Therapy [EGDT]) demonstrated mortality reduction in patients with severe sepsis and expert guidelines have recommended them to clinical practice. Yet, the adoption of these therapies remains low among clinicians.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 4%
Brazil 2 4%
United States 1 2%
Unknown 44 90%

Demographic breakdown

Readers by professional status Count As %
Other 9 18%
Student > Ph. D. Student 7 14%
Student > Postgraduate 5 10%
Student > Master 5 10%
Researcher 4 8%
Other 13 27%
Unknown 6 12%
Readers by discipline Count As %
Medicine and Dentistry 33 67%
Nursing and Health Professions 2 4%
Engineering 2 4%
Social Sciences 2 4%
Philosophy 1 2%
Other 0 0%
Unknown 9 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2018.
All research outputs
#2,913,722
of 22,709,015 outputs
Outputs from PLOS ONE
#38,748
of 193,901 outputs
Outputs of similar age
#8,664
of 83,139 outputs
Outputs of similar age from PLOS ONE
#106
of 365 outputs
Altmetric has tracked 22,709,015 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 193,901 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 83,139 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 365 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.